Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Medical records of patients initiating treatment for Ph- R/R ALL at participating clinical centers in the US between January 2013 and March 2019 will be eligible for inclusion.
You may not be if
Medical records of patients with Ph+ ALL will be excluded.
If informed consent is required, medical records of patients who do not provide informed consent will be excluded.
Clareo Health | An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
